In conclusion, this research demonstrates that in patients living with PBC, whether untreated or receiving first-line therapy, elevations in ALP, TB, AST and ALT and reduction in albumin levels beyond guideline-recommended thresholds are predictive of negative clinical outcomes. This evidence concerns the gene ALB and tuberculosis.